Similar to endless loop tachycardia (ELT), repetitive nonreentrant ventriculoatrial synchrony (RNRVAS) is a ventriculoatrial (VA) synchrony pacemaker-mediated arrhythmia. RNRVAS was first described in 1990 and can only occur in the presence of retrograde VA conduction and dual-chamber or cardiac resynchronization devices with tracking (P-synchronous ventricular pacing such as DDD, DDDR) or nontracking pacing modes that allow AV-sequential pacing (DDI, DDIR). RNRVAS is promoted by (1) high lower rate limit or any feature that allows rapid pacing, (2) long AV intervals, or (3) long postventricular atrial refractory period (PVARP). In contrast to ELT, RNRVAS is a less well-recognized form of pacemaker-mediated arrhythmia; thus, unlike ELT, there are no specific device algorithms to prevent, recognize, and terminate RNRVAS. However, RNRVAS has been recently shown to occur frequently. We present a series of cases, some of which were found fortuitously. Owing to its clinical implications, we propose that algorithms should be developed to prevent, identify, and terminate RNRVAS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.hrthm.2016.04.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Introducing a Novel Pacemaker-Mediated Arrhythmia: The Pseudo-RNRVAS Arising From Atrial Capture Challenges.
Ann Noninvasive Electrocardiol
November 2024
Ankara Guven Hospital, Ankara, Turkey.
Background: This study aimed to define and explain a novel form of pacemaker-mediated arrhythmia which is initiated and sustained by atrial capture loss coinciding with ventriculoatrial (VA) conduction within the postventricular atrial refractory period (PVARP). Unlike repetitive nonreentrant VA synchrony (RNRVAS), in the pseudo-RNRVAS, the atrium is not stimulated due to pacing below the threshold level, rather than because of refractory atrial myocardium.
Objective: The objective was to elucidate the mechanisms of this pseudo-RNRVAS, identify predisposing factors, and propose preventive strategies.
Unique Tachycardia Recorded on a Cardiac Implantable Electronic Device: What is the Mechanism?
Pacing Clin Electrophysiol
December 2024
Department of Cardiology, Soka Municipal Hospital, Soka, Japan.
Article Synopsis
- A 55-year-old man with nonischemic cardiomyopathy experienced a unique tachycardia recorded by an implantable cardioverter defibrillator, raising concerns about its identification and management.
- The report outlines how to differentiate this type of tachycardia from similar heart rhythms and discusses the clinical implications related to patient care.
- It also highlights the limitations of the device in handling these tachycardias and suggests reprogramming strategies to reduce the chances of recurrence, stressing the need for thorough analysis of device-related arrhythmias.
Endless loop tachycardia among patients with devices having advanced preventive algorithms: A case series and brief review.
Pacing Clin Electrophysiol
September 2024
Department of Cardiology, RTIICS, Kolkata, India.
Article Synopsis
- Endless loop tachycardia (ELT) is a frequent issue in patients with implanted cardiac devices and can cause serious symptoms despite preventive measures.
- * A study analyzed 20 cases of sustained ELT from 4,520 device checkups over four years, finding it usually benign but occasionally harmful, particularly in patients with left ventricular dysfunction.
- * Various factors contributed to ELT, including improper AV synchrony and sensing issues, and adjustments like changing sensitivity settings or PVARP duration were necessary for management.
Case report: Torsade de pointes induced by the bigeminy result from retrograde ventriculoatrial activation in VVI pacing and resolved by intentional atrial pacing.
Front Cardiovasc Med
May 2023
Department of Cardiology, Peking University First Hospital, Beijing, China.
Introduction: While pacing has been used for long QT syndrome (LQTs), the optimal pacing modality is controversial.
Case: We report a woman with bradycardia and a recently implanted single-chamber pacemaker experienced multiple syncope. No device dysfunction was found.
Pseudo repetitive non-reentrant ventriculoatrial synchrony: Current challenges.
Pacing Clin Electrophysiol
June 2023
Department of Electrophysiology, Heart Centre, Leipzig at University of Leipzig, Leipzig, Germany.
Background: We recently described a novel pacemaker-mediated arrhythmia in Abbott cardiac implantable electronic devices (CIED), called pseudo-RNRVAS, that mimics repetitive non-reentrant ventriculoatrial synchrony (RNRVAS), but can appear in patients with ventriculoatrial (VA) block. It is caused by sinus-p-waves, trapped in the post-ventricular atrial refractory period (PVARP), which mimic VA conduction. The p-waves are followed by atrial pacing during the myocardial refractory time, which can trigger atrial fibrillation (AF).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!